Publicaciones en las que colabora con Jesús Rodríguez-Baño (16)

2021

  1. Efficacy of β-lactam/β-lactamase inhibitors to treat extended-spectrum beta-lactamase-producing Enterobacterales bacteremia secondary to urinary tract infection in kidney transplant recipients (INCREMENT-SOT Project)

    Transplant infectious disease : an official journal of the Transplantation Society, Vol. 23, Núm. 3, pp. e13520

  2. Propensity score and desirability of outcome ranking analysis of ertapenem for treatment of nonsevere bacteremic urinary tract infections due to extended-spectrum-beta-lactamase-producing enterobacterales in kidney transplant recipients

    Antimicrobial Agents and Chemotherapy, Vol. 65, Núm. 11

2019

  1. Perspective of Spanish medical students regarding undergraduate education in infectious diseases, bacterial resistance and antibiotic use

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 1, pp. 25-30

  2. Rhodomyrtone decreases Staphylococcus aureus SigB activity during exponentially growing phase and inhibits haemolytic activity within membrane vesicles

    Microbial Pathogenesis, Vol. 128, pp. 112-118

2017

  1. High vancomycin MICs predict the development of infective endocarditis in patients with catheter-related bacteraemia due to methicillin-resistant Staphylococcus aureus

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2102-2109

2016

  1. Clinical characteristics, treatment and outcomes of MRSA bacteraemia in the elderly

    Journal of Infection, Vol. 72, Núm. 3, pp. 309-316

2015

  1. Methicillin-resistant Staphylococcus aureus (MRSA) catheter-related bacteraemia in haemodialysis patients

    BMC Infectious Diseases, Vol. 15, Núm. 1

2014

  1. Emergence of resistance to daptomycin in a cohort of patients with methicillin-resistant Staphylococcus aureus persistent bacteraemia treated with daptomycin

    Journal of Antimicrobial Chemotherapy

  2. Lack of association between genotypes and haematogenous seeding infections in a large cohort of patients with methicillin-resistant Staphylococcus aureus bacteraemia from 21 Spanish hospitals

    Clinical Microbiology and Infection, Vol. 20, Núm. 4, pp. 361-367

2013

  1. Predictive factors for mortality in patients with methicillin-resistant Staphylococcus aureus bloodstream infection: Impact on outcome of host, microorganism and therapy

    Clinical Microbiology and Infection, Vol. 19, Núm. 11, pp. 1049-1057

2012

  1. Immunosuppressed patients with pandemic influenza A 2009 (H1N1) virus infection

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 31, Núm. 4, pp. 547-556

  2. Prognosis of 2009 A(H1N1) influenza in hospitalized pregnant women in a context of early diagnosis and antiviral therapy

    Antiviral Therapy, Vol. 17, Núm. 4, pp. 719-728

2011

  1. Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia

    Journal of Infection, Vol. 62, Núm. 3, pp. 193-199

  2. Factors associated with severe disease in hospitalized adults with pandemic (H1N1) 2009 in Spain

    Clinical Microbiology and Infection, Vol. 17, Núm. 5, pp. 738-746

  3. Pneumonia complicating pandemic (H1N1) 2009: Risk factors, clinical features, and outcomes

    Medicine, Vol. 90, Núm. 5, pp. 328-336

  4. Timing of oseltamivir administration and outcomes in hospitalized adults with pandemic 2009 influenza A(H1N1) virus infection

    Chest, Vol. 140, Núm. 4, pp. 1025-1032